Printer Friendly

THE IMMUNE RESPONSE CORPORATION APPOINTS VICE PRESIDENT OF ADMINISTRATION

 THE IMMUNE RESPONSE CORPORATION
 APPOINTS VICE PRESIDENT OF ADMINISTRATION
 SAN DIEGO, Oct. 26 /PRNewswire/ -- The Immune Response Corporation (NASDAQ-NMS: IMNR) today announced the appointment of Paula Baxter Atkins as vice president, administration.
 Atkins began her affiliation with Immune Response in 1987, where she most recently served as executive director of Administration, where she has been responsible for overseeing human resources activities, telecommunications, risk management, safety, security and facilities construction management. She has been instrumental in staffing the firm since its inception and was responsible for overseeing the design and construction of the new corporate research and development facility. Prior to joining Immune Response, Atkins was director of Human Resources and Administration with Access Research Corp. in San Diego and was manager of Compensation with Foodmaker Inc. of San Diego. She has also served as manager of Placement and Employee Services for Scripps Clinic and Research Foundation, La Jolla, and director of Personnel for North County Transit District, Oceanside. Atkins received a bachelor of arts degree and a master of science degree from San Diego State University.
 The Immune Response Corporation is a biopharmaceutical company engaged in the development of products for the treatment of HIV infection, which leads to AIDS, and for the treatment of certain major autoimmune diseases, particularly rheumatoid arthritis, multiple sclerosis and insulin-dependent diabetes.
 -0- 10/26/92
 /CONTACT: Charles J. Cashion, VP-finance of The Immune Response Corporation, 619-431-7080/
 (IMNR) CO: The Immune Response Corporation ST: California IN: MTC SU: PER


LS-JL -- SD003 -- 4710 10/26/92 11:01 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 26, 1992
Words:253
Previous Article:ACC ACQUIRES THIRD CANADIAN LONG-DISTANCE RESELLER
Next Article:CALIFORNIA EXISTING HOME SALES EDGE UP DURING SEPTEMBER
Topics:


Related Articles
IMMULOGIC APPOINTS SENIOR DIRECTOR, REGULATORY AFFAIRS
THE IMMUNE RESPONSE CORPORATION APPOINTS VICE PRESIDENTS OF RESEARCH AND REGULATORY AFFAIRS
AUTOIMMUNE ELECTS HUGH A. D'ANDRADE OF SCHERING-PLOUGH TO BOARD OF DIRECTORS
THE IMMUNE RESPONSE CORPORATION ANNOUNCES ADDITION OF VICE PRESIDENT OF CORPORATE DEVELOPMENT
THE IMMUNE RESPONSE CORPORATION ANNOUNCES ADDITION OF DR. MELVIN PERELMAN TO ITS BOARD OF DIRECTORS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters